CADIAN CAPITAL MANAGEMENT, LP - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 323 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.

Quarter-by-quarter ownership
CADIAN CAPITAL MANAGEMENT, LP ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$70,972,000
-24.8%
550,000
-56.1%
3.14%
-30.1%
Q3 2019$94,338,000
+13.2%
1,252,500
+128.4%
4.48%
+19.3%
Q2 2019$83,345,000
+14.5%
548,500
-10.2%
3.76%
+32.3%
Q1 2019$72,771,000
+136.8%
610,546
+116.9%
2.84%
+98.5%
Q4 2018$30,725,000
-50.9%
281,546
-27.4%
1.43%
-49.7%
Q3 2018$62,601,000
+69.1%
387,600
+38.4%
2.84%
+59.6%
Q2 2018$37,010,000
+76.7%
280,000
-54.9%
1.78%
+74.5%
Q2 2017$20,949,000
+104.7%
621,458
+79.7%
1.02%
+108.4%
Q1 2017$10,236,000
+6.9%
345,811
-0.9%
0.49%
-3.9%
Q4 2016$9,572,000348,9540.51%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Perceptive Advisors 2,878,979$69,182,0007.27%
Eventide Asset Management 259,100$6,226,0000.97%
GLADE BROOK CAPITAL PARTNERS LLC 251,000$6,032,0000.93%
IMS Capital Management 32,215$774,0000.91%
Perceptive Advisors 350,000$8,413,0000.88%
Benchmark Capital Advisors 34,900$839,0000.58%
BECK CAPITAL MANAGEMENT, LLC 24,744$636,0000.49%
SABBY MANAGEMENT, LLC 352,100$8,461,0000.47%
Hatteras Alternative Mutual Funds, LLC 39,404$947,0000.46%
Potomac Capital Management, Inc. 22,100$531,0000.45%
View complete list of SAREPTA THERAPEUTICS INC shareholders